Tag Archives: BPD

Steroids and BPD, what do we really know?

My first foray into systematic review and meta-analysis was about 25 years ago with this article Barrington KJ. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr. 2001;1:1. As you can … Continue reading

Posted in Neonatal Research | Tagged , , , , , | 2 Comments

Optimizing ventilation in established BPD

Babies with established BPD (I won’t worry about the exact diagnostic criteria here, but very preterm infants who are still ventilated as they approach term are the group I am talking about) have somewhat reduced compliance, increased airways resistance, leading … Continue reading

Posted in Neonatal Research | Tagged , | 1 Comment

Automated oxygen control; is it worth it?

The history of automated controls of inspired oxygen goes back many decades, to before the invention of pulse oximetry. The first studies I remember used transcutaneous PO2 as the target variable, which had major limitations, as well as the advantage … Continue reading

Posted in Neonatal Research | Tagged , , , , | 1 Comment

Prophylactic acetaminophen in the preterm

In a newly published trial (Roze JC, et al. Prophylactic Treatment of Patent Ductus Arteriosus With Acetaminophen: A Randomized Clinical Trial. JAMA Pediatr. 2026) nearly 800 infants of 23 to <29 weeks GA were randomized within 12 hours of birth. … Continue reading

Posted in Neonatal Research | Tagged , , , , | 2 Comments

Why doesn’t closing the PDA help preterm infants?

I have been continuing to think about this issue, so will subject you all to some of my thoughts. The large RCTs of medication for closure of the PDA show no benefit, and some evidence of harms, but we all … Continue reading

Posted in Neonatal Research | Tagged , , , | 1 Comment

Should we ever close the PDA?

The latest large multicentre RCT has just been published. Laughon MM, et al. Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm Infants. JAMA. 2025. In this trial, infants of 22 to 28 weeks GA were randomized at between … Continue reading

Posted in Neonatal Research | Tagged , , , , , | 2 Comments

Neonatal Research Shorts : October 2025

Afifi J, et al. Atropine Versus Placebo for Neonatal Nonemergent Intubation: A Randomized Clinical Trial. J Pediatr. 2025;286:114719 I had thought this was a settled issue, Neil Finer showed many years ago that atropine alone decreased bradycardias during intubation. But … Continue reading

Posted in Neonatal Research | Tagged , , , , , , , , , | 2 Comments

Should we be giving erythropoietin, or analogues, to preterm infants?

In some pre-clinical models, erythropoietin acts as a neuroprotective agent, which led to the performance of clinical trials to determine whether there was a positive impact on outcomes of the preterm. The latest study has just been published, and it … Continue reading

Posted in Neonatal Research | Tagged , , , , , , | Leave a comment

Prolonging CPAP in the preterm to improve pulmonary outcomes

I wrote about this trial after last year’s PAS meeting, mentioning that it looked like a potential significant improvement in respiratory care of the preterm The full publication confirms that is a real possibility. McEvoy CT, et al. Extended Continuous … Continue reading

Posted in Neonatal Research | Tagged , , , | 3 Comments

Surfactant plus Budesonide? Not a PLUSS for outcomes

Many of us were already aware of the general direction of the results of this trial, a multi-centre RCT of surfactant with or without budesonide (Manley BJ, et al. Intratracheal Budesonide Mixed With Surfactant for Extremely Preterm Infants. JAMA. 2024), … Continue reading

Posted in Neonatal Research | Tagged , , , , | 2 Comments